Entries are now open for the 19th Annual Scrip Awards.
Firmly established as best-in-class for pharma and biotech, the Scrip Awards on Thursday 16 November will move to our brand-new...
The 2023 Scrip Awards Is Now Open For Entries
Winners To Be Revealed On 16 November
Entries for the Scrip Awards are now open. Now in their 19th year, the Awards seek to reward the outstanding achievements of the pharmaceutical, biotech and allied industries in improving human health.
More from Business
• By
UroGen’s Zusduri was approved despite an advisory committee vote recommending against it in May. It is the first approved drug for a type of recurring bladder cancer.
• By
Private Company Edition: Antares’ lead asset will enter the clinic in 2026 after Lilly committed up to $2.5bn for Scorpion’s Phase I/II PI3Kα inhibitor STX-478. Also, Amplify raised $200m for its first biotech VC fund and Mosanna raised an $80m series A round, among other financings.
• By
The Belgian drugmaker is boosting its biologics capacity over the pond.
• By
After in-licensing a cardiovascular candidate last year, AstraZeneca has signed a strategic drug discovery alliance, which could generate billions of dollars in payments to the Chinese firm.
More from Scrip
• By
After in-licensing a cardiovascular candidate last year, AstraZeneca has signed a strategic drug discovery alliance, which could generate billions of dollars in payments to the Chinese firm.
Recent moves in the industry include changes at the top at iOnctura and Orca Bio, plus Sutro Biopharma, Tenpoint Therapeutics and Helix BioPharma get new CFOs.
• By
Study to add to safety and tolerability data for infused formulation and may help identify optimal dose for future pivotal trial.